After speaking with the developer of a trading course designed to
flourish in any market and any time frame, and he verified that for a
short time he's giving away the first 5 chapters of this step-by-step,
A to Z trading 'secrets' course for the first time.

Let's be honest. If you're like most traders, you'll probably just
delete this e-mail and not take action on it. But in my opinion, it's
the smart traders that take that extra 15 seconds throughout their day
to acquire extra trading knowledge wherever they can get it. What's it
going to cost you? 15 seconds? Is that a good deal or a GREAT deal?

Here's the link > http://tinyurl.com/ya4vhdw

The good news is that if can 'pull the trigger' and go to the link
below, you're already ahead of most traders that just won't take the
time to acquire new knowledge. Here's a summary of what those smart
traders will get with my compliments in this 5 chapter trading
preview...

** Introduction

** The Top 11 Trading Myths

** The Bad News & The Good News

** Tools

** Trading Indicators & Methods

Go here now to get this complimentary 'sneak peek' > http://tinyurl.com/ya4vhdw

And also, you're also going to get 3 extra bonus eBooks that you can
add to your personal Wealth Archive.

** Discovering Stock Trading's Winning Edge

** Choosing a Trading System That Actually Works

** The Truth About Winning Edge Trading

Go to this page to claim all this material today > http://tinyurl.com/ya4vhdw

If you're like me, I know you probably already visited the link above
because you're constantly in learning mode, and are truly a 'student
for life' in all aspects of your professional and personal life.

To Your Success,
The Stock Market Club

P.S. Go ahead, take 15 seconds and claim your 5 chapters of these
trading 'secrets', plus grab your 3 complimentary eBooks at >
http://tinyurl.com/ya4vhdw

http://sndp500.blogspot.com/2009/11/test3.html

Dear Friends:

EcoBlu Products Inc. (OTC: ECOB) has signed an exclusive licensing
agreement with fire protection supplier Megola

Check it Out    http://www.sddt.com/news/article.cfm?SourceCode=20091119czb

An Eco-Friendly WORLD is a DREAM of all and ECO Blu Products ECOB is
one such stepping stone towards it.  www.EcoBluProducts.com

ECOB  Products; a fully integrated chemical coating plant located in
Southern California and Northeast Texas, poised to impact housing
industry on many levels.

ECOB aims at preventing rot, mildew, fungus, termite infestation,
along with effective fire retardant. Coated wood lasts Lifelong;
increases sustainability of forests.

Estimated Market demand for treated lumber is $11 Billion by 2010.
Demand for lumber and engineering wood products is expected to be $18
Billion.

The management team made up to Founder Steve Conboy and EVP Mark
Vuzzo, having more than 30 years of experience each; and the Advisory
team consisting of Ken McClelland- president of McClelland
Organization. The ECoBlu seems to be in have a great leaders.

ECO Blu is superbly positioned to take advantage in this rapidly
increasing eco friendly and Green market.
ECOB  have an estimated growth of about $6 billion within 3 years.
This would represent a gain of over 200% from current level.

The wood chemical market enjoyed $2 Billion in revenues in 2007, ones
the global financial market recovers the revenues are expected to
exceed the numbers.

Partnership with Lowe’s had enabled EcoBlu to implement new strategies
and boost contractor sales.

EcoBlu have established Nationwide Sales and Marketing of coatings
chemistry in South America, Caribbean, Africa and Asia.

A Three year plan of ECOB calls for direct selling of chemicals
coatings to mills, EWP manufacturers and independent coaters in the US
and elsewhere, than just selling to retailers and other small
builders.

Check out Complete Presentation only at www.stockexploder.com

 Please do your own due diligence on ECOB

http://n4sd4q.blogspot.com/2009/11/test.html

(MASP) has generated $1,792,808 (usd) in operating revenue as compared
to $32,000 (usd) in operating revenue for the third quarter, 2008,
Which is an increase of 5,600%.

(MASP) reports net income of $14,794 for the third quarter, 2009
versus a loss of $59,724 for the same period in 2008, which is a 500%
increase.

(MASP) also reported total assets of $500,000,000 for the third
quarter, 2009 as compared to $100,000,000 for the third quarter, 2008,
which is a 500% increase.

The increase in all revenue streams is due to the acquisition of the
Canadian Basin Oil / Gas & Gold reserves. The Canadian Basin assets is
valued at {$400 Million USD}. The Oil & Gas reserves have 500 Million
barrels of proved oil & 2 Billion barrels of Probable reserves. A chip
of gold showed an average of 6.1g/t Au over 9m (37ft). Confirming
excellent gold mineral results.

The current 3 out of 20 wells in the Canadian Basin have generated
{$1.7 Million USD} in revenue or a projected {$23 Million USD} / year.
The 3 commercial wells have an average daily production rate of 4584
barrels/ day.

www.masspetroleum.com

oh wow...an Apple Fan Boy and his pithy commentary

On Nov 20, 1:16 pm, RMH <rmh...@gmail.com> wrote:

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Peopel can save lot of money if they use dell computer ----------on
family planning and heating
Heat generated by the dell laptop is sufficient to check your potency
and sterility......bad news
Heat generated by this equipment is sufficient to keep your house
warm.. ... good news
Sound generated by its fan is very melodious too!!!!!!!!!!
I do hope dell will be more prifitable atleast in this way in  the
future!!!!!!!!!!

Hope dell will relaise these problems in their future products

Market Mafia - http://groups.google.com/group/market-mafia?hl=en

Market Mafia is now accepting new members. To subscribe just click the
link above and request to join. This opportunity will not last long.
Our most recent pick was PWRM which was announced at 0.10 on 11/17/09
and reached a day high of 0.22 on 11/18. The next pick will be
announced Monday morning before the market opens. Ensure you are
subscribed before then to ensure a great entry point. Good luck
traders!

Dead man walkin!

was the beginning of the run on this stock, the price raised over
0,10!... the run on this stock last till 12-12.

I predicted the raise at the opening today. Now there are some
playing
around and didn't we promissed to buy a 20 million shares when
reaching 0,0012? This will be one of the biggest gainers next monday.

The Canadian Basin assets is valued at {$400 Million USD}. The Oil &
Gas reserves have 500 Million barrels of proved oil & 2 Billion
barrels of Probable reserves. The acquisition has been approved &
finalized.

Taking economic factors into account & with gold prices rising steady
& the logistics of the property, (MASP) feels this property warrants
becoming their number one focus.

3 wells in the Canadian Basin have generated {$17 Million USD} in
revenue or a projected {$230 Million USD} / year. The commercial wells
have Produced a total amount of 236625 barrels with an average daily
production rate of 4584 barrels/ day. All assets yield a total daily
production rate of 25000 barrels / day.

www.masspetroleum.com

MASS Petroleum, Inc. Ticker symbol is MASP, Google finance has been
advised that the ticker symbol MASPE is invalid & that updates be made
as soon as possible. You can visit www.pinksheets.com for all the
current Charts / Press Releases / Company info.

Dear Friends:

Our Exploding New Pick is Vivakor, Inc. VIVK http://www.vivakor.com/

VIVK is a trans-disciplinary biomedical/biotechnology company involved
in Discovering, Developing and Commercializing Solutions that
positively impact life. www.vivakor.com

VIVK plans to adapt a $300 Million potential technology upgrade to
produce and enhance MRI images which might improve MRI resolution
along with providing additional data such a blood flow velocity in
images tissues.

Market potential of about $15 Million just within 12 month
commercialization of the electro-optical devices released by VIVK.

VIVK have a fully integrated specialist team working on clinical trial
on Digital Photo screener, Opti-Ear and Anemia Monitor, having a
completion time of late 2009, positive results may drastically reduce
overall time and cost from previously used technology.

Experienced BOD Matthew Nicosia, Dr.Tannin Fuju and John Grayga have
strategically grown the revenue of VIVK from $20 Million to $120
Million. They approved a dividend to every share holders. Each share
holder will receive one HealthAmerica share for every share of Vivakor
Inc.

VIVK is currently in collaboration with University of IOWA, developing
a digital photo refractor that is intended to modernize child vision
screening. Approval has been granted from Western Institutional Review
Borad(20080731) to conduct human validation study.

VIVK has developed a series of nutraceutical formulations, including
VivaBlend, and plan to develop additional nutraceuticals, botanicals
and supplements. VIVK recently received 25000 units purchase order for
one of their products.

Critical advancement in the biological sample preservation are also
been evolved in VIVK. They have developed specialized Cryovials that
accommodate an improved method of cryopreservation of cells, blood and
other bio-materials.

VIVK have recently launched its sales products to Exploding Indian
Biotech market. Biopharma remains India’s biggest sector, accounting
for nearly 70% of the total revenues, expected to be worth US $5.7
Billion by 2012-2013. The future of the bio-supplier industry in India
looks very bright and so does of VIVK.

Check out Complete Presentation only at www.stockexploder.com
Please do your own due diligence on VIVK
All The Best

Exploder

www.stockexploder.com
 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html

Dear Friends:

Our Exploding New Pick is Vivakor, Inc. VIVK http://www.vivakor.com/

VIVK is a trans-disciplinary biomedical/biotechnology company involved
in Discovering, Developing and Commercializing Solutions that
positively impact life. www.vivakor.com

VIVK plans to adapt a $300 Million potential technology upgrade to
produce and enhance MRI images which might improve MRI resolution
along with providing additional data such a blood flow velocity in
images tissues.

Market potential of about $15 Million just within 12 month
commercialization of the electro-optical devices released by VIVK.

VIVK have a fully integrated specialist team working on clinical trial
on Digital Photo screener, Opti-Ear and Anemia Monitor, having a
completion time of late 2009, positive results may drastically reduce
overall time and cost from previously used technology.

Experienced BOD Matthew Nicosia, Dr.Tannin Fuju and John Grayga have
strategically grown the revenue of VIVK from $20 Million to $120
Million. They approved a dividend to every share holders. Each share
holder will receive one HealthAmerica share for every share of Vivakor
Inc.

VIVK is currently in collaboration with University of IOWA, developing
a digital photo refractor that is intended to modernize child vision
screening. Approval has been granted from Western Institutional Review
Borad(20080731) to conduct human validation study.

VIVK has developed a series of nutraceutical formulations, including
VivaBlend, and plan to develop additional nutraceuticals, botanicals
and supplements. VIVK recently received 25000 units purchase order for
one of their products.

Critical advancement in the biological sample preservation are also
been evolved in VIVK. They have developed specialized Cryovials that
accommodate an improved method of cryopreservation of cells, blood and
other bio-materials.

VIVK have recently launched its sales products to Exploding Indian
Biotech market. Biopharma remains India’s biggest sector, accounting
for nearly 70% of the total revenues, expected to be worth US $5.7
Billion by 2012-2013. The future of the bio-supplier industry in India
looks very bright and so does of VIVK.

Check out Complete Presentation only at www.stockexploder.com

Please do your own due diligence on VIVK
All The Best

Exploder

www.stockexploder.com

 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html
tock exploder

Dear Friends:

Our Exploding New Pick is Vivakor, Inc. VIVK http://www.vivakor.com/

VIVK is a trans-disciplinary biomedical/biotechnology company involved
in Discovering, Developing and Commercializing Solutions that
positively impact life. www.vivakor.com

VIVK plans to adapt a $300 Million potential technology upgrade to
produce and enhance MRI images which might improve MRI resolution
along with providing additional data such a blood flow velocity in
images tissues.

Market potential of about $15 Million just within 12 month
commercialization of the electro-optical devices released by VIVK.

VIVK have a fully integrated specialist team working on clinical trial
on Digital Photo screener, Opti-Ear and Anemia Monitor, having a
completion time of late 2009, positive results may drastically reduce
overall time and cost from previously used technology.

Experienced BOD Matthew Nicosia, Dr.Tannin Fuju and John Grayga have
strategically grown the revenue of VIVK from $20 Million to $120
Million. They approved a dividend to every share holders. Each share
holder will receive one HealthAmerica share for every share of Vivakor
Inc.

VIVK is currently in collaboration with University of IOWA, developing
a digital photo refractor that is intended to modernize child vision
screening. Approval has been granted from Western Institutional Review
Borad(20080731) to conduct human validation study.

VIVK has developed a series of nutraceutical formulations, including
VivaBlend, and plan to develop additional nutraceuticals, botanicals
and supplements. VIVK recently received 25000 units purchase order for
one of their products.

Critical advancement in the biological sample preservation are also
been evolved in VIVK. They have developed specialized Cryovials that
accommodate an improved method of cryopreservation of cells, blood and
other bio-materials.

VIVK have recently launched its sales products to Exploding Indian
Biotech market. Biopharma remains India’s biggest sector, accounting
for nearly 70% of the total revenues, expected to be worth US $5.7
Billion by 2012-2013. The future of the bio-supplier industry in India
looks very bright and so does of VIVK.

Check out Complete Presentation only at www.stockexploder.com

Please do your own due diligence on VIVK
All The Best

Exploder

www.stockexploder.com

 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html
tock exploder